Day 1

ODYSSEY LONG TERM: Safety and efficacy of long-term alirocumab

solaci
solaci
460
0

This was a prospective, randomized, controlled study comparing monoclonal antibody alirocumab with placebo in patients with hypercholesterolemia and high cardiovascular risk. At 24 weeks follow-up LDL cholesterol reduction with alirocumab was 61% versus 0.8% placebo (p <0.0001). This reduction was maintained at 52 weeks. 

 

12_jennifer_robinson
Jennifer Robinson
2014-08-31

Original title: Long-term safety, tolerability and efficacy of alirocumab versus placebo in high cardiovascular risk patients: first results from the ODYSSEY LONG TERM study in 2,341 patients.

 

Previous article
LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients
Next article
BIOSCIENCE study: Absorbable polymer versus permanent in sirolimus-eluting stents
solaci
solaci

More articles by this author

LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients

solaci - 0
The treatment of hyperlipidemia is useful in primary and secondary prevention of chronic heart disease and stroke, particularly in diabetic patients. Many statins may...

COPPS-2: Colchicine for prevention of post-pericardiotomy syndrome and postoperative atrial fibrillation

solaci - 0
180 patients with colchicine 0.5 mg twice daily from 48-72 hs. before surgery versus 180 patients to placebo were randomized. The medication was continued...

ODYSSEY FH I and FH II: Alirocumab in patients with heterozygous familial hypercholesterolemia

solaci - 0
The study included patients with a diagnosis of heterozygous familial hypercholesterolemia who were receiving the maximum tolerated dose of randomized statin alirocumab 75 mg...

SIGNIFY: Ivabradine does not reduce events in patients with stable coronary disease

solaci - 0
The increase in heart rate in the setting of chronic coronary artery disease is associated with poor prognosis, especially increased risk of acute myocardial...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 1

LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients

The treatment of hyperlipidemia is useful in primary and secondary prevention of chronic heart disease and stroke, particularly in diabetic...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Dr. Andrés Rodríguez - 0
Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Dr. Juan Manuel Pérez - 0
Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Dr. Juan Manuel Pérez - 0
Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...